2.6. Data collection
This protocol is extracted from research article:
The therapeutic effects of naringenin on bronchial pneumonia in children
Pharmacol Res Perspect, Jul 26, 2021; DOI: 10.1002/prp2.825

All basic information of the recruited children was collected through the hospital's electronic records. Additional data, such as family history of allergy and comorbidities, were extracted through a questionnaire before they joined in the clinical trial. Data of patient laboratory blood tests and diagnosis of clinical symptoms were also collected from the hospital's electronic records.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.